229 related articles for article (PubMed ID: 18000743)
1. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
2. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
3. Pathomechanisms of paraneoplastic myasthenia gravis.
Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.
Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A
Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022
[TBL] [Abstract][Full Text] [Related]
5. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
[TBL] [Abstract][Full Text] [Related]
6. CD4
Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A
Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113
[TBL] [Abstract][Full Text] [Related]
7. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
8. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
10. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.
Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
14. The CD4(+)CD8(+) and CD4(+) subsets of FOXP3(+) thymocytes differ in their response to growth factor deprivation or stimulation.
Lehtoviita A; Rossi LH; Kekäläinen E; Sairanen H; Arstila TP
Scand J Immunol; 2009 Oct; 70(4):377-83. PubMed ID: 19751272
[TBL] [Abstract][Full Text] [Related]
15. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
[TBL] [Abstract][Full Text] [Related]
16. Delineation of chicken thymocytes by CD3-TCR complex, CD4 and CD8 antigen expression reveals phylogenically conserved and novel thymocyte subsets.
Davidson NJ; Boyd RL
Int Immunol; 1992 Oct; 4(10):1175-82. PubMed ID: 1489733
[TBL] [Abstract][Full Text] [Related]
17. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients.
Tackenberg B; Schlegel K; Happel M; Eienbröker C; Gellert K; Oertel WH; Meager A; Willcox N; Sommer N
J Neuroimmunol; 2009 Nov; 216(1-2):85-91. PubMed ID: 19781791
[TBL] [Abstract][Full Text] [Related]
18. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B
J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus.
Takeuchi Y; Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
Cell Immunol; 1995 Apr; 161(2):181-7. PubMed ID: 7697728
[TBL] [Abstract][Full Text] [Related]
20. T lymphocyte activation in myasthenic thymoma.
Takahashi K; Saito S; Monden Y
Autoimmunity; 1998; 28(3):173-82. PubMed ID: 9867130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]